Breast Cancers with HER2 and CEP17 "Co-Amplification" by FISH: Pathologic Features and Clinical Outcomes

被引：0

作者：

Ballard, Morgan

Troxell, Megan

Jensen, Kristin

Allison, Kimberly H.

机构：

[1] Stanford Univ, Med Ctr, Stanford, CA 94305 USA

[2] Palo Alto VA Healthcare, Palo Alto, VA USA

来源：

LABORATORY INVESTIGATION | 2017年 / 97卷

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

112

引用

页码：31A / 31A

页数：1

共 50 条

[21] Comparative Pathologic Analysis of Breast Cancers Classified as HER2/neu-Amplified by FISH using a Standard HER2/CEP17 Dual Probe and an Alternative HER2/LIS1 Dual Probe: An Analysis of 1201 Cancers.
Zare, Somaye
Lin, Leo
Alghamdi, Abrar G.
Roma, Andres
Hasteh, Farnaz
Dell'Aquila, Marie
Fadare, Oluwole
MODERN PATHOLOGY, 2018, 31 : 117 - 117
[22] Prognostic value of HER2/CEP17 ratio in HER2-positive early breast cancer by FISH testing
Zheng, F.
Du, F.
Yuan, P.
ANNALS OF ONCOLOGY, 2022, 33 : S155 - S155
[23] HER2/Neu Gene Amplification Heterogeneity: The Significance of Cells with a 3:1 HER2/CEP17 Ratio
Layfield, L. J.
Schmidt, R.
LABORATORY INVESTIGATION, 2012, 92 : 49A - 49A
[24] Incidence and Significance of Fluorescent In Situ Hybridization (FISH) HER2 Gene Amplification by HER2 Gene Copy Number of ≥6.0 with Her2/CEP17 Ratio of <2.0 in Breast Cancer
Apple, Sophia
MODERN PATHOLOGY, 2017, 30 : 29A - 30A
[25] HER2/neu Gene Amplification Heterogeneity: The Significance of Cells With a 3:1 HER2/CEP17 Ratio
Layfield, Lester J.
Schmidt, Robert L.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2012, 20 (06) : 543 - 549
[26] HER2/Neu Gene Amplification Heterogeneity: The Significance of Cells with a 3:1 HER2/CEP17 Ratio
Layfield, L. J.
Schmidt, R.
MODERN PATHOLOGY, 2012, 25 : 49A - 49A
[27] Discordance between HER2 Copies/Cell and HER2/CEP17 Ratio by Fluorescence In Situ Hybridization (FISH) in Invasive Breast Carcinoma
Czapla, A.
Silverman, J. F.
Krishnamurti, U.
MODERN PATHOLOGY, 2014, 27 : 43A - 43A
[28] Incidence and Significance of Fluorescent In Situ Hybridization (FISH) HER2 Gene Amplification by HER2 Gene Copy Number of ≥ 6.0 with Her2/CEP17 Ratio of <2.0 in Breast Cancer
Apple, Sophia
LABORATORY INVESTIGATION, 2017, 97 : 29A - 30A
[29] Discordance between HER2 Copies/Cell and HER2/CEP17 Ratio by Fluorescence In Situ Hybridization (FISH) in Invasive Breast Carcinoma
Czapla, A.
Silverman, J. F.
Krishnamurti, U.
LABORATORY INVESTIGATION, 2014, 94 : 43A - 43A
[30] Prevalence of polysomy 17 by OncoScan in Fluorescence In Situ Hybridization (FISH) HER2 Gene amplification by HER2 gene copy number of > 6.0 with HER2/CEP17 ratio of < 2.0 in breast cancer
Apple, Sophia
Murata-Collins, Joyce
MODERN PATHOLOGY, 2018, 31 : 45 - 45

← 1 2 3 4 5 →